Macrogenics Inc
MGNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001125345
In the last 90 days, Macrogenics Inc insiders filed 0 open-market purchases and 1 sale; 122 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Macrogenics Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 135
- +2 vs. Q2 2022
- Shares held
- 57.5M
- −5.10M (−8.1%) vs. Q2 2022
- Total value
- $199.0M
- +$14.1M (+7.6%) vs. Q2 2022
- New holders
- 20
- 43 more added
- Sold out
- 18
- 50 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 122 | $224.9M |
| Q1 2026 | 109 | $124.8M |
| Q4 2025 | 89 | $64.3M |
| Q3 2025 | 104 | $77.4M |
| Q2 2025 | 112 | $58.5M |
| Q1 2025 | 129 | $68.3M |
| Q4 2024 | 129 | $182.5M |
| Q3 2024 | 124 | $187.9M |
| Q2 2024 | 147 | $258.9M |
| Q1 2024 | 163 | $953.6M |
| Q4 2023 | 143 | $595.1M |
| Q3 2023 | 127 | $270.5M |
| Q2 2023 | 131 | $321.1M |
| Q1 2023 | 137 | $419.1M |
| Q4 2022 | 135 | $380.5M |
| Q3 2022 | 135 | $199.0M |
| Q2 2022 | 133 | $184.9M |
| Q1 2022 | 144 | $531.2M |
| Q4 2021 | 156 | $918.1M |
| Q3 2021 | 154 | $1.21B |
| Q2 2021 | 149 | $1.54B |
| Q1 2021 | 174 | $1.80B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Macrogenics Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Principal Financial Group Inc | 265,424 | $918.0K | 0.00% | +3,471+1.3% | Added |
| Woodline Partners LP | 269,272 | $932.0K | 0.01% | 00.0% | Unchanged |
| Caxton Associates LP | 283,388 | $981.0K | 0.17% | +265,779+1,509.3% | Added |
| JPMorgan Chase & Co | 329,456 | $1.14M | 0.00% | −69,598−17.4% | Reduced |
| Two Sigma Investments, LP | 393,683 | $1.36M | 0.00% | −598,884−60.3% | Reduced |
| Charles Schwab Investment Management Inc | 401,635 | $1.39M | 0.00% | +27,652+7.4% | Added |
| Pinnacle Associates Ltd | 417,528 | $1.45M | 0.03% | +23,109+5.9% | Added |
| Macquarie Group Ltd | 420,490 | $1.46M | 0.00% | −782−0.2% | Reduced |
| Goldman Sachs Group Inc | 463,035 | $1.60M | 0.00% | −121,770−20.8% | Reduced |
| Citadel Advisors LLC | 465,029 | $1.61M | 0.00% | −627,420−57.4% | Reduced |
| Dimensional Fund Advisors LP | 470,093 | $1.63M | 0.00% | −445,801−48.7% | Reduced |
| Nuveen Asset Management, LLC | 497,439 | $1.72M | 0.00% | +170,615+52.2% | Added |
| Renaissance Technologies LLC | 509,223 | $1.76M | 0.00% | −921,700−64.4% | Reduced |
| AQR Capital Management LLC | 536,331 | $1.86M | 0.00% | +395,809+281.7% | Added |
| D. E. Shaw & Co., Inc. | 580,553 | $2.01M | 0.00% | −265,100−31.3% | Reduced |
| Frazier Life Sciences Management, L.P. | 701,631 | $2.43M | 0.19% | +701,631 | New |
| Northern Trust Corp | 765,916 | $2.65M | 0.00% | +193,503+33.8% | Added |
| Morgan Stanley | 779,348 | $2.70M | 0.00% | +101,899+15.0% | Added |
| Baker Bros. Advisors LP | 892,579 | $3.09M | 0.02% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 930,955 | $3.22M | 0.10% | +930,955 | New |
| Two Sigma Advisers, LP | 946,700 | $3.28M | 0.01% | −73,500−7.2% | Reduced |
| Acadian Asset Management LLC | 1,017,083 | $3.52M | 0.02% | +180,088+21.5% | Added |
| Geode Capital Management, LLC | 1,048,513 | $3.63M | 0.00% | +23,242+2.3% | Added |
| Rock Springs Capital Management LP | 1,206,642 | $4.17M | 0.11% | +251,914+26.4% | Added |
| State Street Corp | 1,377,304 | $4.76M | 0.00% | +108,750+8.6% | Added |
| Federated Hermes, Inc. | 1,410,599 | $4.88M | 0.01% | +303,053+27.4% | Added |
| Assenagon Asset Management S.A. | 1,798,258 | $6.22M | 0.03% | −2,405−0.1% | Reduced |
| T. Rowe Price Investment Management, Inc. | 2,882,009 | $9.97M | 0.01% | +2,882,009 | New |
| Wasatch Advisors Inc | 2,900,049 | $10.0M | 0.07% | −1,490,015−33.9% | Reduced |
| Millennium Management LLC | 3,541,952 | $12.3M | 0.02% | +932,390+35.7% | Added |
| Vanguard Group Inc | 4,182,241 | $14.5M | 0.00% | +251,279+6.4% | Added |
| BlackRock Inc. | 5,722,945 | $19.8M | 0.00% | +372,141+7.0% | Added |
| Armistice Capital, LLC | 6,128,000 | $21.2M | 0.53% | 00.0% | Unchanged |
| Bellevue Group AG | 7,325,514 | $25.3M | 0.36% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 3 | – | – | +3 | New |
| RTW Investments, LP | 0 | $0 | 0.00% | −3,975,554−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,227,202−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −686,855−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −208,300−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −176,710−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −94,987−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −80,485−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −75,200−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −71,224−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −68,996−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −19,920−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −13,316−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −10,262−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −10,286−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −675−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −472−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |